Gedeon Richter has launched a dydrogesterone-only hormone replacement therapy (HRT) formulation in the UK, Nalvee, as an option for non-hysterectomised women receiving oestrogen therapy. Nalvee marks ...

The Rural Health Transformation Program represents the largest federal investment in rural healthcare in history to modernize ...

A cheap Virginia Beach rideshare option may vanish in January. One Virginia Wesleyan University student wants city leadership to prevent that from happening.

The debut of the Ford Mustang GT3 in next year’s Meguiar’s Bathurst 12 Hour will be a “milestone moment” for the brand according to Ford Racing’s global sports car manager Alex Allmandinger.

Ford will debut the Mustang GT3 at the 2026 Bathurst 12 Hour with a factory-backed Germany’s Haupt Racing Team.

Haupt Racing Team will expand its efforts with the Ford Mustang GT3 next year, entering selected Intercontinental GT Challenge rounds in addition to a return to DTM, ADAC GT Masters and GT World ...

Hormonal changes are a natural part of aging, but for many women, the effects can feel anything but natural. Hot flashes that interrupt the day, sleep disturbances that derail focus, mood fluctuations ...

After months of hesitation and a lot of research, I began my HRT journey last year. I'd been battling anxiety, brain fog and hot sweats for months, and following an appointment with an online ...

Dear Dr. Roach: What are your thoughts on hormone replacement therapy (HRT) for women? I've heard that the results that essentially stopped HRT for decades were flawed in their interpretation. Is this ...

DEAR DR. ROACH: What are your thoughts on hormone replacement therapy (HRT) for women? I’ve heard that the results that essentially stopped HRT for decades were flawed in their interpretation. Is this ...

A growing number of experts believe one common menopause medication could stop tinnitus in its tracks among midlife women. The condition – a constant ringing or buzzing in the ears, even when no ...

Women who use hormone replacement therapy (HRT) for at least a decade before their final period may see a reduced risk of breast cancer, heart attacks, or strokes, according to a new analysis.